Quantification of target cell killing dependent on CD20 organization
| Profile of capping . | Percent of conjugates . | Conjugates with killing . | 
|---|---|---|
| No capping | 17.6% (21/119)* | 42.9% (9/21) | 
| Capping | 82.4% (98/119)* | 68.4% (67/98) | 
| Localization of cap | ||
| Capping elsewhere | 44.9% (44/98)† | 61.4% (27/44) | 
| Capping on contact side | 55.1% (54/98)† | 74.1% (40/54) |